CareFusion Launches New Preoperative Cleansing Program For In-Home Patient Use

CareFusion Launches New Preoperative Cleansing Program For In-Home Patient Use

StartClean Program Includes Unique e-Reminder System to Drive Bathing
Compliance

PR Newswire

SAN DIEGO, Nov. 13, 2012

SAN DIEGO, Nov. 13, 2012 /PRNewswire/ --CareFusion Corp. (NYSE: CFN), a
leading, global medical technology company, today unveiled a new preoperative
cleansing program for patients that includes an industry-first, individualized
reminder program that helps patients remember and follow a clinician's
preoperative bathing instructions.

Many organizations including the Centers for Disease Control, Association of
periOperative Registered Nurses, and the Institute for Healthcare
Improvement's Project JOINTS Initiative recommend preoperative bathing prior
to hospital admission as part of the pre-surgical process. In fact, in a
recent survey of 151 surgeons, 94 percent recommended a bathing protocol to
help reduce the risk of contracting a health care associated infection while
in the hospital.[1] However, patient compliance with preoperative bathing at
home remains low. In a study published in the September 2010 edition of the
Journal of Arthroplasty, less than 14 percent of patients fully comply with a
clinician's preoperative bathing instructions at home.[2]

The StartClean program drives compliance with physician bathing instructions
by combining a chlorhexidine gluconate (CHG) cleanser and sponges with an
individualized service that sends reminders to comply with preoperative
bathing instructions via text message, email or voicemail in the days or hours
leading up to a procedure. StartClean was specifically designed to support
initiatives at hospitals and other points of care to drive compliance with
preoperative bathing instructions.

"Quality health care delivery has always been epitomized by the essential
communication between patient and caregiver," said Allan J. Morrison, M.D.,
MSc, FACP, FIDSA, FSHEA of Inova Fairfax Hospital. "A recent study reinforced
the power of good communication when it reported that sending text messages to
parents increased the rate of seasonal child flu vaccinations compared with a
single telephone reminder. [3] The StartClean program includes the use of
multi-media messaging – through email, text or voicemail – to enhance the
likelihood of patients completing their preoperative cleansing prior to their
scheduled surgery. This is the future of health care."

The StartClean cleansing kit contains one, 4-ounce bottle of 4 percent CHG and
three single-use sponges in an easy-to-open peel back package. The reminder
program includes the individualized e-alerts, an easy-to-read patient
education sheet available in multiple languages and supplemental online
resources for health care professionals.

Health care practitioners can find more information at
carefusion.com/StartClean.

About CareFusion Corporation

CareFusion (NYSE: CFN) is a global corporation serving the health care
industry with products and services that help hospitals measurably improve the
safety and quality of care. The company develops market-leading technologies
including Alaris® infusion pumps, Pyxis® automated dispensing and patient
identification systems, AVEA®, AirLife™ and LTV® series ventilation and
respiratory products, ChloraPrep® products, MedMined® services for data mining
surveillance, V. Mueller® surgical instruments, and an extensive line of
products that support interventional medicine. CareFusion employs more than
15,000 people across its global operations. More information may be found at
www.carefusion.com.

[1] 2011 Bernstein Rein survey of 151 surgeons.

[2] Johnson, A., Daley, J., Zywiel, M., Delanois, R. et al. "Preoperative
chlorhexidine preparation and the incidence of surgical site infections after
hip arthroplasty," September 2010, The Journal of Arthroplasty, 25(6):98–102.

[3] Stockwell MS, et al "Effect of a text messaging intervention on influenza
vaccination in an urban, low-income pediatric and adolescent population: A
randomized controlled trial" JAMA 2012;307: 1702-1708.

SOURCE CareFusion Corp.

Website: http://www.carefusion.com
Contact: Media, Troy Kirkpatrick, +1-858-617-2361,
troy.kirkpatrick@carefusion.com, or Investors, Jim Mazzola, +1-858-617-1203,
jim.mazzola@carefusion.com
 
Press spacebar to pause and continue. Press esc to stop.